Treating patients of myelodysplastic syndrome with antithymocytic globulin-should we be more selective? [4] (multiple letters)

Blood

Volumn 102, Issue 10, 2003, Pages 3851-3852

  Madkaikar, Manisha ^c   Ghosh, Kanjaksha ^a   Steensma, David P ^b   Dispenzieri, Angela ^c   Tefferi, Ayalew ^c  

^a KEM HOSPITAL   (India)

^b MAYO CLINIC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DANAZOL; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOIMMUNE DISEASE; DRUG SELECTIVITY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LETTER; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0242578089     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-08-2803     Document Type: Letter

References (0)